| Literature DB >> 15620626 |
Carrine A Burns1, Marc D Brown.
Abstract
Imiquimod is a topically applied immunomodulator. Although initially approved for genital and perianal warts, dermatologists have prescribed this compound for many neoplastic and nonneoplastic skin conditions. The US Food and Drug Administration recently approved imiquimod for the treatment of actinic keratoses. This article reviews the literature on imiquimod in the treatment of cutaneous malignancies.Entities:
Mesh：
Substances：
Year: 2005 PMID： 15620626 DOI： 10.1016/j.det.2004.08.007
Source DB: PubMed Journal: Dermatol Clin ISSN： 0733-8635 Impact factor: 3.478